Alembic Pharmaceuticals share news, announcements and annual reports
NSE: APLLTDBSE: 533573Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹794.85.
30 Oct: open ₹794.85, high ₹800.00, low ₹784.05
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,683 Cr430th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.69
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.76
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.50%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.24
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 72,86569.4% delivered
Alembic Pharmaceuticals routine notices
390 filed, newest first. Page 6 of 8.
Oct 2022
20 Oct · Routine
10 Oct · Routine
Sep 2022
30 Sep · Routine
27 Sep · Routine
20 Sep · Routine
16 Sep · Routine
8 Sep · Routine
Aug 2022
26 Aug · Routine
24 Aug · Routine
23 Aug · Routine
8 Aug · Routine
8 Aug · Routine
Jul 2022
21 Jul · Routine
20 Jul · Routine
18 Jul · Routine
15 Jul · Routine
5 Jul · Routine
5 Jul · Routine
Jun 2022
30 Jun · Routine
28 Jun · Routine
23 Jun · Routine
May 2022
23 May · Routine
23 May · Routine
19 May · Routine
13 May · Routine
13 May · Routine
Mar 2022
31 Mar · Routine
28 Mar · Routine
1 Mar · Routine
Feb 2022
24 Feb · Routine
16 Feb · Routine
14 Feb · Routine
Jan 2022
28 Jan · Routine
25 Jan · Routine
18 Jan · Routine
17 Jan · Routine
13 Jan · Routine
13 Jan · Routine
12 Jan · Routine
3 Jan · Routine
3 Jan · Routine
Dec 2021
28 Dec · Routine
13 Dec · Routine
8 Dec · Routine